Jennison Associates LLC Boosts Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Jennison Associates LLC increased its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 76.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 870,588 shares of the company's stock after acquiring an additional 377,225 shares during the quarter. Jennison Associates LLC owned about 0.53% of Option Care Health worth $30,427,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the fourth quarter worth approximately $26,000. Signaturefd LLC lifted its stake in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares during the period. Bessemer Group Inc. lifted its stake in Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after buying an additional 599 shares during the period. Quadrant Capital Group LLC lifted its stake in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after buying an additional 1,099 shares during the period. Finally, Public Employees Retirement System of Ohio lifted its stake in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on OPCH. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JMP Securities restated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Wednesday, June 18th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Stock Down 1.5%

Option Care Health stock traded down $0.46 during trading on Friday, hitting $29.48. 954,581 shares of the company were exchanged, compared to its average volume of 1,830,733. The business's 50 day moving average is $31.58 and its 200 day moving average is $31.67. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a market capitalization of $4.83 billion, a P/E ratio of 23.77, a PEG ratio of 1.78 and a beta of 0.73. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the company posted $0.26 earnings per share. Option Care Health's revenue was up 16.3% compared to the same quarter last year. Analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.